Simple urine test could predict lung cancer treatment success
NCT ID NCT05928299
First seen May 21, 2026 · Last updated May 21, 2026
Summary
This study looked at whether proteins and metabolites in blood and urine can help doctors monitor how well immunotherapy is working in people with advanced non-small cell lung cancer. Researchers tested samples from 150 patients before, during, and after treatment. The goal was to find patterns that could signal whether the cancer is responding or getting worse, without needing invasive biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang hospital
Guangzhou, Guangdong, 510400, China
Conditions
Explore the condition pages connected to this study.